Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- US wants extra Winter Olympics spot for skeleton’s Uhlaender
- Ryan Coogler's Jim Crow-era vampire film 'Sinners' makes Hollywood history with 16 Oscar nominations
- Steve Coogan on how his Irish identity drew him to an infamous bust-up | Ents & Arts News
- Turkish pro-Kurd DEM party warns of 'humanitarian tragedy' in siege on Syria's Kobane
- Germany weighs boon and bane of China’s industrial expansion
- 2026 Oscar Nominees: Surprises and Snubs
- Is China quietly winning the AI race?
- Hyrox is super populair: sportarts ziet voordelen, maar ook valkuilen
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
